Who should receive early anti-TNF therapy: With what benefits and risks? Ted Denson, MD Cincinnati Childrens Hospital Medical Center University of Cincinnati.
NO16968: XELOXA Adjuvant Treatment with Capecitabine and Oxaliplatin (XELOX) in Stage III Colon Cancer ESMO/ECCO Presidential Session III D. Haller, J.
Surgical Management of Colorectal Hepatic Metastases
Efficacy findings from a randomized phase III trial of capecitabine plus oxaliplatin versus bolus 5-FU/LV for stage III colon cancer (NO16968): No impact.
ESMO/ECCO Presidential Session III
Poster Session ASCO GI, San Franciso, CA, 15 January 2009
Mts epatiche - Roma 20071 Optimal Management of Liver Metastases: Present Results and Future Strategies Highlights in the Management of CRC Roma, 1-2 febbraio.
